4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-18-009834
Chief Technology Officer sold 14,000 shares at an average $35.63 ($498,872)
- Chief Technology Officer acquired 14,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Myer Vickesh · Chief Technology Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-17 | Exercise or conversion : show line 1 in the form | +3,000 | $0.65 | $1,950 | 3,000 | D |
| 2018-07-17 | Sale : show line 2 in the form | −3,000 | $34.66 | $103,980 | 0 | D |
| 2018-07-17 | Exercise or conversion : show line 3 in the form | +4,000 | $0.65 | $2,600 | 4,000 | D |
| 2018-07-17 | Sale : show line 4 in the form | −4,000 | $36.50 | $146,000 | 0 | D |
| 2018-07-18 | Exercise or conversion : show line 5 in the form | +6,150 | $11.21 | $68,942 | 6,150 | D |
| 2018-07-18 | Sale : show line 6 in the form | −6,150 | $35.46 | $218,079 | 0 | D |
| 2018-07-18 | Exercise or conversion : show line 7 in the form | +850 | $11.21 | $9,529 | 850 | D |
| 2018-07-18 | Sale : show line 8 in the form | −850 | $36.25 | $30,813 | 0 | D |
| Open-market sales · 14,000 sh · avg $35.63 · $498,872 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-07-17 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −7,000 | 97,307 | D |
| 2018-07-18 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −7,000 | 76,897 | D |
Loading xslF345X03/edgar.xml…